title: [Should Helicobacter pylori infection be taken into account in the use of nonsteroidal anti-inflammatory agents?].
authors.affiliation: Service des Maladies de l'Appareil Digestif, Hôpital Pontchaillou, Rennes.
authors.forename: J F
authors.initials: JF
authors.lastname: Bretagne
authors.forename: M
authors.initials: M
authors.lastname: Pagenault
authors.forename: A
authors.initials: A
authors.lastname: Bourienne
authors.forename: D
authors.initials: D
authors.lastname: Heresbach
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D051546:Cyclooxygenase 2; D004415:Dyspepsia / Q000139:chemically induced / Q000150:complications; D016481:Helicobacter Infections / Q000150:complications* / Q000201:enzymology / Q000453:epidemiology / Q000503:physiopathology; D016480:Helicobacter pylori; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D008565:Membrane Proteins; D010437:Peptic Ulcer / Q000139:chemically induced / Q000150:complications / Q000503:physiopathology; D010544:Peroxidases / Q000378:metabolism; D015995:Prevalence; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007527:Isoenzymes; D008565:Membrane Proteins; D010544:Peroxidases; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases